Evidence From Human Myectomy Samples That MYBPC3 Mutations Cause Hypertrophic Cardiomyopathy Through Haploinsufficiency S Marston, ON Copeland, A Jacques, K Livesey, V Tsang, WJ McKenna, ... Circulation research 105 (3), 219-222, 2009 | 293 | 2009 |
Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis C Marti, N Garin, O Grosgurin, A Poncet, C Combescure, S Carballo, ... Critical Care 16, 1-12, 2012 | 279 | 2012 |
β-Lactam monotherapy vs β-lactam–macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial N Garin, D Genné, S Carballo, C Chuard, G Eich, O Hugli, O Lamy, ... JAMA internal medicine 174 (12), 1894-1901, 2014 | 276 | 2014 |
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity A Quercioli, Z Pataky, G Vincenti, V Makoundou, V Di Marzo, ... European heart journal 32 (11), 1369-1378, 2011 | 151 | 2011 |
Prognosis of patients with familial hypercholesterolemia after acute coronary syndromes D Nanchen, B Gencer, O Muller, R Auer, S Aghlmandi, D Heg, ... Circulation 134 (10), 698-709, 2016 | 137 | 2016 |
Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy S Carballo, P Robinson, R Otway, D Fatkin, JDH Jongbloed, N De Jonge, ... Circulation research 105 (4), 375-382, 2009 | 118 | 2009 |
Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline T Kuijpers, FA Spencer, RAC Siemieniuk, PO Vandvik, CM Otto, L Lytvyn, ... Bmj 362, 2018 | 112 | 2018 |
Determining prognosis in acute exacerbation of COPD Y Flattet, N Garin, J Serratrice, A Perrier, J Stirnemann, S Carballo International journal of chronic obstructive pulmonary disease, 467-475, 2017 | 108 | 2017 |
Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score R Klingenberg, S Aghlmandi, L Räber, B Gencer, D Nanchen, D Heg, ... European Heart Journal: Acute Cardiovascular Care 7 (2), 129-138, 2018 | 107 | 2018 |
Low-dose computed tomography for the diagnosis of pneumonia in elderly patients: a prospective, interventional cohort study V Prendki, M Scheffler, B Huttner, N Garin, F Herrmann, JP Janssens, ... European Respiratory Journal 51 (5), 2018 | 87 | 2018 |
Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation A Quercioli, Z Pataky, F Montecucco, S Carballo, A Thomas, C Staub, ... JACC: Cardiovascular Imaging 5 (8), 805-815, 2012 | 86 | 2012 |
Acute respiratory and cardiovascular admissions after a public smoking ban in Geneva, Switzerland JP Humair, N Garin, E Gerstel, S Carballo, D Carballo, PF Keller, ... PloS one 9 (3), e90417, 2014 | 57 | 2014 |
Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes B Gencer, N Rodondi, R Auer, L Räber, R Klingenberg, D Nanchen, ... European journal of internal medicine 26 (1), 56-62, 2015 | 52 | 2015 |
Medical students’ perceptions and coping strategies during the first wave of the COVID-19 pandemic: studies, clinical implication, and professional identity S Wurth, J Sader, B Cerutti, B Broers, NM Bajwa, S Carballo, M Escher, ... BMC medical education 21 (1), 620, 2021 | 50 | 2021 |
Eligibility for PCSK 9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines … B Gencer, KC Koskinas, L Räber, A Karagiannis, D Nanchen, R Auer, ... Journal of the American Heart Association 6 (11), e006537, 2017 | 47 | 2017 |
Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy C Serratrice, S Carballo, J Serratrice, JÃ Stirnemann Core evidence, 37-47, 2016 | 44 | 2016 |
Outcome in acute heart failure: prognostic value of acute kidney injury and worsening renal function G Berra, N Garin, J Stirnemann, AS Jannot, PY Martin, A Perrier, ... Journal of cardiac failure 21 (5), 382-390, 2015 | 43 | 2015 |
Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes B Gencer, R Auer, D Nanchen, L Räber, R Klingenberg, D Carballo, ... Atherosclerosis 239 (1), 118-124, 2015 | 42 | 2015 |
Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelines KC Koskinas, B Gencer, D Nanchen, M Branca, D Carballo, ... European journal of preventive cardiology 28 (1), 59-65, 2021 | 41 | 2021 |
Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medications R Auer, B Gencer, L Räber, R Klingenberg, S Carballo, D Carballo, ... PloS one 9 (3), e93147, 2014 | 39 | 2014 |